Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study

谢切诺夫学报
Sechenovskii vestnik

ISSN 2218-7332 (Print)
ISSN 2658-3348 (Online)

用户

eng | рус | 简体中

谢切诺夫学报

高级搜索

过刊浏览

下载PDF文件

全屏

浏览 PDF (Rus): 649

本作品遵循 Creative Commons Attribution 3.0 License 授权许可.

ISSN 2218-7332 (Print)
ISSN 2658-3348 (Online)

热门文章

主编

彼得·格雷鲍奇卡

Article Tools

查找参考文献

Email this article (Login required)

发送邮件给作者 (Login required)

About The Authors

Sechenov First Moscow State Medical University (Sechenov University)
俄罗斯联邦

Elena V. Poddubskaya, PhD, Deputy Director of Clinical Center for Oncology

Moscow

Sechenov First Moscow State Medical University (Sechenov University)
俄罗斯联邦

Marina I. Sekacheva, DMSc, Professor, Director of the Institute for Personalized Medicine, Director of the Center for Personalized Oncology Sechenov OncoTarget

Moscow

Sechenov First Moscow State Medical University (Sechenov University)
俄罗斯联邦

Anastasia A. Guryanova, 5th year student of the International School "Medicine of the Future" of Biomedical Science & Technology Park

8/2 Trubetskaya st., Moscow, 119991
Tel.: +7 (927) 173-00-35

通知

用户名
密码
	##plugins.block.user.rememberMe##
注册本站新用户。忘记您的密码?

用户

谢切诺夫学报

Cookies的使用